Consensus Development Conference on Insulin Resistance: 5–6 November 1997

@article{1998ConsensusDC,
  title={Consensus Development Conference on Insulin Resistance: 5–6 November 1997},
  author={},
  journal={Diabetes Care},
  year={1998},
  volume={21},
  pages={310 - 314}
}
  • Published 1 February 1998
  • Medicine
  • Diabetes Care
The possibility that there can be defects in the sensitivity of tissues to insulin action in people with diabetes was first reported nearly 50 years ago (1). Since then many investigators have described, with increasing detail, the pathogenesis and consequences of what has become known as "insulin resistance." As our understanding of the biology of glucose homeostasis has grown, insulin resistance has clearly emerged as an important cause of glucose intolerance leading to type 2 diabetes, and… 
Insulin resistance and β‐cell dysfunction as therapeutic targets in type 2 diabetes
TLDR
The roles attributable to insulin resistance and impaired b-cell function in type 2 diabetes are summarized and the assessment of insulin Resistance and insulin action are considered.
Insulin resistance and risk for stroke
TLDR
Six of the nine studies are methodologically sound and provide evidence that insulin resistance is associated with risk for stroke and new drugs can safely reduce insulin resistance and may have a role in stroke prevention.
I NSULIN RESISTANCE-WHAT IS MYTH AND WHAT IS REALITY ?
Diabetes mellitus is a complex disorder of the energy metabolism of the human body. In the last WHO/ADA classification, the main forms of this disease are Type 1 (T1DM) and Type 2 (T2DM) diabetes
A Review of Contemporary Markers of Insulin Resistance
  • E. Lawson
  • Computer Science
    International Journal of Diabetes and Endocrinology
  • 2019
TLDR
It is hoped that with the advancement in medical research, more markers of insulin resistance will be discovered that will help in patient managements.
Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications
Type 2 diabetes primarily develops from pathogenic defects in the mechanisms of insulin secretion and hepatic and peripheral insulin action. The consequent disruption of normal glucose metabolism
Assessing Insulin Resistance: Application of a Fasting Glucose to Insulin Ratio in Growth Hormone-Treated Children
TLDR
It is concluded that simple measures of IR such as the FGIR may be useful in screening and following patients at risk for IR.
Insulin Resistance: Cellular and Clinical Concepts
  • W. Cefalu
  • Medicine
    Experimental biology and medicine
  • 2001
TLDR
The presence of insulin resistance is observed many years before the onset of clinical hyperglycemia and the diagnosis of Type 2 diabetes, and appears to be significantly associated with a clustering of cardiovascular risk factors predisposing the individual to accelerated cardiovascular disease.
PPARs, Insulin Resistance and Type 2 Diabetes
TLDR
It is clear that the PPAR receptors are exciting targets for therapeutic compounds likely to impact on insulin sensitivity, lipid and glucose homeostasis and vascular disease, and whether these compounds, which improve insulin sensitivity and beta-cell function, will impact on the natural history of the disease.
Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals.
TLDR
It is suggested that the incorporation of fasting free fatty acid level into QUICKI is useful to improve its correlation with the clamp-based index of insulin sensitivity and its discriminatory power in case of mild insulin resistance.
Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers.
TLDR
It was concluded that aspirin and rosiglitazone offer unique approaches for treatment of type 2 diabetes due to their insulin-sensitizing and anti-inflammatory properties, and their combination was found to provide augmented beneficial effects.
...
1
2
3
4
5
...

References

SHOWING 1-7 OF 7 REFERENCES
Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study
TLDR
A minimum model of glucose disposal and insulin secretion based on intravenous glucose tolerance tests to estimate insulin sensitivity, glucose effectiveness, and first-phase and second-phase beta-cell responsiveness in normoglycaemic offspring of couples who both had type 2 diabetes found that insulin secretion was appropriate for the level of insulin resistance.
Role of Insulin Resistance in Human Disease
TLDR
The possibility is raised that resistance to insulin-stimulated glucose uptake and hyperinsulinemia are involved in the etiology and clinical course of three major related diseases— NIDDM, hypertension, and CAD.
Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp.
TLDR
These methods are equivalent for assessment of overall insulin sensitivity in normal and insulin-resistant nondiabetic subjects.
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
Methods for the quantification of beta-cell sensitivity to glucose (hyperglycemic clamp technique) and of tissue sensitivity to insulin (euglycemic insulin clamp technique) are described.
Task Force on Standardization of the Insulin Assay ( Task Force Report )
  • 1996